Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Effective oral and injectable PrEP have put a damper on the development of new HIV prevention methods, but women need a variety of options.
Previous research has shown low rates of use of HIV prevention products, but the tide could be turning.
Little HIV prevention research has included pregnant women for fear of adverse birth outcomes.
Early studies of dapivirine lubricant for anal sex indicate how far the field has come—and how far it still has to go.
To date, no head-to-head trial has compared the prevention methods.
The safety trial will enroll pregnant women in several sub-Saharan African nations.
A recent study found that the antiretroviral-containing ring was safe and that the girls in the trial used it well.
NIAID research will build on the ASPIRE trials. Those findings showed that dapivirine rings provided “modest” HIV protection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.